Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Orthopaedics
Published in: International Orthopaedics 6/2006

01-12-2006 | Original Paper

Use of purified beta-tricalcium phosphate for filling defects after curettage of benign bone tumours

Authors: M. Hirata, H. Murata, H. Takeshita, T. Sakabe, Y. Tsuji, T. Kubo

Published in: International Orthopaedics | Issue 6/2006

Login to get access

Abstract

Fifty-three patients with benign bone tumours were treated with curettage and filling with a purified beta-tricalcium phosphate (β-TCP). Recurrences occurred in two cases. There was neither a postoperative infection nor adverse reaction due to the material. Postoperative fractures did not occur in any patients. Radiographically, complete resorption of the material and bone remodelling were achieved in 23 cases (43%). Of these 23 cases, there was a statistical correlation between the filling volume and the time taken for complete resorption (p<0.05). We concluded that purified β-TCP was an ideal bone graft substitute for the treatment of benign bone tumours because of its good biocompatibility and resorption characteristics.
Literature
1.
Altermatt S, Schwobel M, Pochon JP (1992) Operative treatment of solitary bone cysts with tricalcium phosphate ceramic: a 1 to 7 year follow-up. Eur J Pediatr Surg 2:180–182PubMedCrossRef
2.
Arrington ED, Smith WJ, Chambers HG, Bucknel AL, Davino NA (1996) Complication of iliac crest bone graft harvesting. Clin Orthop 329:300–309PubMedCrossRef
3.
Banwart JC, Asher MA, Hassanein RS (1995) Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine 20:1055–1060PubMedCrossRef
4.
Bucholz RW (2002) Nonallograft osteoconductive bone graft substitutes. Clin Orthop 395:44–52PubMed
5.
Dong J, Uemura T, Shirasaki Y, Tateishi T (2002) Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow-derived osteoprogenitor cells. Biomaterials 23:4493–4502PubMedCrossRef
6.
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumours of the musculoskeletal system. Clin Orthop 286:241–246PubMed
7.
Galois L, Mainnard D, Delagoutte JP (2002) Beta-tricalcium phosphate ceramic as a bone substitute in orthopaedic surgery. Int Orthop 26:109–115PubMedCrossRef
8.
Matsumine A, Myoui A, Kusuzaki K, Araki N, Seto M, Yoshikawa H, Uchida A (2004) Calcium hydroxyapatite ceramic implants in bone tumour surgery. A long-term follow-up study. J Bone Joint Surg Br 86:719–725PubMedCrossRef
9.
Nicholas RW, Lange TA (1994) Granular tricalcium phosphate grafting of cavity lesions in human bone. Clin Orthop 306:197–203PubMed
10.
Ogose A, Hotta T, Hatano H, Kawashima H, Tokunaga K, Endo N, Umezu H (2002) Histological examination of beta-tricalcium phosphate graft in human femur. J Biomed Mater Res 63:601–604PubMedCrossRef
11.
Ohyama T, Kubo Y, Iwata H, Taki W (2002) Beta-tricalcium phosphate as a substitute for autograft in interbody fusion cages in the canine lumbar spine. J Neurosurg 97(Suppl 3):350–354PubMed
12.
Uchida A, Araki N, Shinto Y, Yoshikawa H, Kurishiki E, Ono K (1990) The use of calcium hydroxyapatite ceramic in bone tumour surgery. J Bone Join Surg Br 72:298–302
13.
Yamada Y, Boo JS, Ozawa R, Nagasaka T, Okazaki Y, Hata K, Ueda M (2003) Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. J Craniomaxillofac Surg 31:27–33PubMed
14.
Yamamoto T, Onga T, Marui T, Mizuno K (2000) Use of hydroxyapatite to fill cavities after excision of benign bone tumours: clinical results. J Bone Join Surg Br 82:1117–1120CrossRef
15.
Metadata
Title
Use of purified beta-tricalcium phosphate for filling defects after curettage of benign bone tumours
Authors
M. Hirata
H. Murata
H. Takeshita
T. Sakabe
Y. Tsuji
T. Kubo
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
International Orthopaedics / Issue 6/2006
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-006-0156-1

Other articles of this Issue 6/2006

International Orthopaedics 6/2006 Go to the issue

Original Paper

Role of staged endoprosthetic revision with flap cover for limb salvage in endoprosthetic failure

Original Paper

The microbiology of infected hip arthroplasty

Original Paper

Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant

Original Paper

Treatment results of pathological fractures of the long bones: a retrospective analysis of 88 patients

Original Paper

Intramedullary knee arthrodesis as a salvage procedure after failed total knee replacement

Original Paper

Histologically verified lung metastases in benign giant cell tumours—14 cases from a single institution